Skip to main content

Amyloidosis

  • Chapter
Clinical Hepatology
  • 1875 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Buxbaum J (1998) The amyloidoses. In: Klippel JH, Dippe PA (eds) Rheumatology, 2nd edn. Mosby, London, pp 8.27.1–10

    Google Scholar 

  2. Caballería J, Bruguera M, Solé M, et al (2001) Hepatic familial amyloidosis caused by a new mutation in the AI gene: clinical and pathological features. Am J Gastroenterol 96: 1872–6

    PubMed  Google Scholar 

  3. Furie B, Voo L, McAdam KPWJ, et al (1981) Mechanism of Factor X deficiency in systemic amyloidosis. N Engl J Med 304: 827–30

    Article  CAS  PubMed  Google Scholar 

  4. Gertz MA, Kyle RA (1997) Hepatic amyloidosis: clinical appraisal in 77 patients. Hepatology 25: 118–21

    Article  CAS  PubMed  Google Scholar 

  5. Greenstein AJ, Sachar DB, Panday AK, et al (1992) Amy-loidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore) 71: 261–70

    CAS  Google Scholar 

  6. Holmgren G, Ericson BG, Groth CG, et al (1993) Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341: 1113–6

    Article  CAS  PubMed  Google Scholar 

  7. Llovat LB, Persey MR, Madhoo S, et al (1998) The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients. Gut 42: 727–34

    Article  Google Scholar 

  8. Obici L, Palladini G, Giorgetti S, et al (2004) Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families. Gastroenterology 126: 1416–22

    Article  PubMed  Google Scholar 

  9. Park MA, Mueller PS, Kyle RA, et al (2003) Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore) 82: 291–8

    Article  Google Scholar 

  10. Peters RA, Koukoulis G, Gimson A, et al (1994) Primary amyloidosis and severe intrahepatic cholestatic jaundice. Gut 35: 1322–5

    Article  CAS  PubMed  Google Scholar 

  11. Reuben A (2004) The legend of the lardaceous liver. Hepa-tology 40: 763–6

    Google Scholar 

  12. Rockey DC (1999) Striking cholestatic liver disease: a distinct manifestation of advanced primary amyloidosis. South Med J 92: 236–41

    Article  CAS  PubMed  Google Scholar 

  13. Saeger W, Röcken Ch (1998) Amyloid: Mikroskopischer Nachweis, Klassifikation und klinischer Bezug. Pathologe 19: 345–54

    Article  CAS  PubMed  Google Scholar 

  14. Suhr OB, Holmgren G, Steen L, et al (1995) Liver transplantation in familial amyloidotic polyneuropathy. Follow- up of the first 20 Swedish patients. Transplantation 15: 933–8

    Google Scholar 

  15. Volwiler W, Jones CM (1947) The diagnostic and therapeutic value of liver biopsies, with particular reference to trocar biopsy. N Engl J Med 237: 651–6

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dancygier, H. (2010). Amyloidosis. In: Clinical Hepatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04519-6_33

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04519-6_33

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04509-7

  • Online ISBN: 978-3-642-04519-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics